Clinical, epidemiological and therapeuthic study of 402 patients with American cutaneous leishmaniasis seen at University Hospital of Brasilia, DF, Brazil [PDF]
FUNDAMENTOS – A leishmaniose tegumentar americana é doença em expansão no Brasil. A região Centro- Oeste é hoje a terceira em incidência e a primeira em crescimento da doença.
Name, Roberto Querido +5 more
core +3 more sources
The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate [PDF]
Pentavalent antimonials are the standard treatment for cutaneous leishmaniasis (CL) with low efficacy and resistance is emerging. CL is increased significantly in respect to incidence rate and expanding to new foci.
Barati, Mohammad +7 more
core
Review and new therapeutic alternatives for the treatment of cutaneous Leishmaniasis [PDF]
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/63704Leishmaniasis comprises a group of diseases caused by protozoa of the genus Leishmania and has two basic clinical forms, visceral Leishmaniasis and cutaneous Leishmaniasis. The clinical
Pujol Brugués, Alba +1 more
core
Objective: To characterize the pediatric population with cutaneous leishmaniasis treated at a research center and to determine the therapeutic response and safety of the treatment.
Susana Ríos-Echavarría +3 more
doaj +1 more source
Influence of Leishmania (Viannia) Species on the Response to Antimonial Treatment in Patients with American Tegumentary Leishmaniasis [PDF]
Background. Pentavalent antimonials (SbV) are the first-line chemotherapy for American tegumentary leishmaniasis (ATL). There are, however, reports of the occurrence of treatment failure with these drugs.
Adaui, Vanessa +12 more
core
Retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimoniate
We retrospectively analyzed a series of 151 cases of cutaneous leishmaniasis treated between 1967 and 1982. One-hundred-and-thirty-nine (92%) patients presented with active lesions and were treated with daily doses of meglumine antimoniate: 81 adults ...
Armando de Oliveira Schubach +7 more
doaj
2025 ACVIM Forum Research Abstract Program
Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley +1 more source
Antileishmanial potentials of azacitidine and along with meglumine antimoniate on Leishmania major: In silico prediction and in vitro analysis. [PDF]
Derakhshani A +9 more
europepmc +1 more source
Review on the risks associated to allopurinol therapy in dogs with canine Leishmaniosis [PDF]
PòsterJun
Universitat Autònoma de Barcelona. Facultat de Veterinària +1 more
core
Green Synthesis, Characterization, and Antileishmanial Activity of the Silver Nanoparticles Alone and Along with Meglumine Antimoniate against Leishmania major Infection. [PDF]
Majeed QA, Shater AF, Alanazi AD.
europepmc +1 more source

